Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2

Aim – to study the features of immunohistochemical expression of MMP-9, TIMP-1, MMP/TIMP ratio in the cerebral cortex in diabetes mellitus type 2. Materials and methods. A pathomorphological and immunohistochemical study of the section material of brain tissue conducted in 3 groups of observation...

Full description

Saved in:
Bibliographic Details
Main Authors: V. O. Shavrin, Yu. M. Avramenko
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2020-08-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/208355/211683
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849703508606976000
author V. O. Shavrin
Yu. M. Avramenko
author_facet V. O. Shavrin
Yu. M. Avramenko
author_sort V. O. Shavrin
collection DOAJ
description Aim – to study the features of immunohistochemical expression of MMP-9, TIMP-1, MMP/TIMP ratio in the cerebral cortex in diabetes mellitus type 2. Materials and methods. A pathomorphological and immunohistochemical study of the section material of brain tissue conducted in 3 groups of observations: group I – control without diabetes and cerebrovascular pathology, group II – deceased patients with dyscirculatory-ischemic encephalopathy (DIE), group III – deceased patients with diabetes mellitus type 2 (DM). Results. Increased expression of MMP-9 in DIE group and in deceased patients with DM type 2 (MMP-9 in the control group – 0.434 (0.399; 0.792) %, in DIE group – 0.652 (0.398; 1.103) %, in DM type 2 group – 0.829 (0.636; 1.034) % has been found. A significant decrease in TIMP-1 expression was detected in DM type 2 (TIMP-1 – in the control group 0.449 (0.254; 0.601) %, in group of DIE – 0.444 (0.306; 0.688) %, in DM type 2 group – 0.278 (0.196; 0.554) %. A statistically significant increase in the MMP/TIMP ratio (Р ˂ 0.05) was observed in DM, the median was 2.732 (1.665; 4.643); this indicator was 1.386 (0.618; 2.29) in the control group and 1.528 (0.619; 3.056) (Р ˃ 0.05) in DIE group. Conclusions. An increase in the level of MMP-9 expression and a decrease in the expression level of TIMP-1 in the cerebral cortex in diabetes mellitus type 2 promote increased blood-brain barrier permeability and is an important link in the pathogenesis of diabetic microangiopathy.
format Article
id doaj-art-10ff16692b9842bebe1bcb873c066a13
institution DOAJ
issn 2306-4145
2310-1210
language English
publishDate 2020-08-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj-art-10ff16692b9842bebe1bcb873c066a132025-08-20T03:17:14ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102020-08-0122446847210.14739/2310-1210.2020.4.208355://doi.org/10.14739/2310-1210.2020.4.208355Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2V. O. Shavrin Yu. M. AvramenkoAim – to study the features of immunohistochemical expression of MMP-9, TIMP-1, MMP/TIMP ratio in the cerebral cortex in diabetes mellitus type 2. Materials and methods. A pathomorphological and immunohistochemical study of the section material of brain tissue conducted in 3 groups of observations: group I – control without diabetes and cerebrovascular pathology, group II – deceased patients with dyscirculatory-ischemic encephalopathy (DIE), group III – deceased patients with diabetes mellitus type 2 (DM). Results. Increased expression of MMP-9 in DIE group and in deceased patients with DM type 2 (MMP-9 in the control group – 0.434 (0.399; 0.792) %, in DIE group – 0.652 (0.398; 1.103) %, in DM type 2 group – 0.829 (0.636; 1.034) % has been found. A significant decrease in TIMP-1 expression was detected in DM type 2 (TIMP-1 – in the control group 0.449 (0.254; 0.601) %, in group of DIE – 0.444 (0.306; 0.688) %, in DM type 2 group – 0.278 (0.196; 0.554) %. A statistically significant increase in the MMP/TIMP ratio (Р ˂ 0.05) was observed in DM, the median was 2.732 (1.665; 4.643); this indicator was 1.386 (0.618; 2.29) in the control group and 1.528 (0.619; 3.056) (Р ˃ 0.05) in DIE group. Conclusions. An increase in the level of MMP-9 expression and a decrease in the expression level of TIMP-1 in the cerebral cortex in diabetes mellitus type 2 promote increased blood-brain barrier permeability and is an important link in the pathogenesis of diabetic microangiopathy.http://zmj.zsmu.edu.ua/article/view/208355/211683diabetes mellitusangiogenesismmp-9timp-1mmp-9/timp-1
spellingShingle V. O. Shavrin
Yu. M. Avramenko
Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
Zaporožskij Medicinskij Žurnal
diabetes mellitus
angiogenesis
mmp-9
timp-1
mmp-9/timp-1
title Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
title_full Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
title_fullStr Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
title_full_unstemmed Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
title_short Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
title_sort immunohistochemical characteristics of mmp 9 and timp 1 markers expression in the cerebral cortex in diabetes mellitus type 2
topic diabetes mellitus
angiogenesis
mmp-9
timp-1
mmp-9/timp-1
url http://zmj.zsmu.edu.ua/article/view/208355/211683
work_keys_str_mv AT voshavrin immunohistochemicalcharacteristicsofmmp9andtimp1markersexpressioninthecerebralcortexindiabetesmellitustype2
AT yumavramenko immunohistochemicalcharacteristicsofmmp9andtimp1markersexpressioninthecerebralcortexindiabetesmellitustype2